• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-27a和miR-31在结直肠癌早期诊断及预后中的意义

Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer.

作者信息

Cui Qingjun

机构信息

Department of Laboratory, Xintai People's Hospital, Xintai, Shandong 271200, P.R. China.

出版信息

Oncol Lett. 2019 Sep;18(3):3092-3096. doi: 10.3892/ol.2019.10621. Epub 2019 Jul 16.

DOI:10.3892/ol.2019.10621
PMID:31452786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6676396/
Abstract

Clinical significance of micro-ribonucleic acid (miR)-27a and miR-31 in the early diagnosis and prognosis of colorectal cancer were investigated. Forty patients with colorectal malignancy admitted to Xintai People's Hospital from February 2014 to April 2018 were enrolled as the observation group, of which 30 patients were diagnosed via pathological biopsy. Another 40 patients diagnosed with colorectal polyp and receiving surgical treatment were selected as the control group. The relative amount of miR-27a and miR-31 was measured. The relative expression levels of miR-27a and miR-31 in patients were analyzed. The diagnostic sensitivity, specificity and accordance rates of positive miR-27a and miR-31 expression in colorectal cancer were recorded. The correlation of the relative expression levels of miR-27a and miR-31 with the survival time of patients were analyzed. In the observation group, the relative expression levels of miR-27a and miR-31 in patients with lymph node metastasis and distant metastasis were higher than those in patients without lymph node metastasis and distant metastasis (P<0.05). Histological type of patients with non-mucinous carcinoma had increased relative expression levels of miR-27a and miR-31 in comparison with those with mucinous carcinoma (P<0.05). In terms of Duke's grade, the relative expression levels of miR-27a and miR-31 in patients with grade C and D were higher than those in patients with grade A and B (P<0.05). The diagnostic sensitivity, specificity and accordance rate of positive miR-27a expression were lower than those of positive miR-31 expression. The relative expression levels of miR-27a and miR-31 were positively correlated with the survival time of patients (P<0.05). The expression levels of miR-27a and miR-31 are related to distant metastasis and tumor grade of patients with colorectal cancer, and positively associated with the survival time of patients, having high diagnostic value.

摘要

研究了微小核糖核酸(miR)-27a和miR-31在结直肠癌早期诊断及预后中的临床意义。选取2014年2月至2018年4月新泰市人民医院收治的40例结直肠恶性肿瘤患者作为观察组,其中30例经病理活检确诊。另选取40例诊断为结直肠息肉并接受手术治疗的患者作为对照组。检测miR-27a和miR-31的相对含量。分析患者中miR-27a和miR-31的相对表达水平。记录miR-27a和miR-31阳性表达在结直肠癌中的诊断敏感性、特异性及符合率。分析miR-27a和miR-31相对表达水平与患者生存时间的相关性。观察组中,有淋巴结转移和远处转移患者的miR-27a和miR-31相对表达水平高于无淋巴结转移和远处转移患者(P<0.05)。非黏液腺癌患者的miR-27a和miR-31相对表达水平高于黏液腺癌患者(P<0.05)。在杜克分期方面,C期和D期患者的miR-27a和miR-31相对表达水平高于A期和B期患者(P<0.05)。miR-27a阳性表达的诊断敏感性、特异性及符合率低于miR-31阳性表达。miR-27a和miR-31的相对表达水平与患者生存时间呈正相关(P<0.05)。miR-27a和miR-31的表达水平与结直肠癌患者的远处转移及肿瘤分级有关,且与患者生存时间呈正相关,具有较高的诊断价值。

相似文献

1
Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer.miR-27a和miR-31在结直肠癌早期诊断及预后中的意义
Oncol Lett. 2019 Sep;18(3):3092-3096. doi: 10.3892/ol.2019.10621. Epub 2019 Jul 16.
2
Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.彩色多普勒超声联合血浆 miR-21 和 miR-27a 对乳腺癌的诊断价值。
Clin Transl Oncol. 2021 Apr;23(4):709-717. doi: 10.1007/s12094-020-02501-9. Epub 2020 Nov 18.
3
The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.miR-27a 的增加影响顺铂对肝癌细胞增殖和迁移能力的作用。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5490-5498. doi: 10.26355/eurrev_201809_15809.
4
Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer.循环外泌体 miR-27a 和 miR-130a 可作为结直肠癌的新型诊断和预后生物标志物。
Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):746-754. doi: 10.1158/1055-9965.EPI-18-0067. Epub 2018 May 8.
5
Expression and clinical value of miR-27a in serum of patients with skin squamous cell carcinoma.血清 miR-27a 在皮肤鳞状细胞癌患者中的表达及临床价值。
J BUON. 2020 Sep-Oct;25(5):2515-2522.
6
Clinical Significance of MiR-27a Expression in Serum Exosomes in Patients with Heart Failure.心力衰竭患者血清外泌体 miR-27a 表达的临床意义。
Cell Mol Biol (Noisy-le-grand). 2022 Feb 4;67(5):324-331. doi: 10.14715/cmb/2021.67.5.44.
7
Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.微小RNA-27a在骨肉瘤中的诊断和预后潜力
Biomed Pharmacother. 2015 Apr;71:222-6. doi: 10.1016/j.biopha.2015.01.025. Epub 2015 Feb 7.
8
MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.微小RNA-27a通过直接靶向PH结构域和富含亮氨酸重复序列的蛋白磷酸酶2促进胃癌细胞的恶性行为。
J Exp Clin Cancer Res. 2017 Mar 21;36(1):45. doi: 10.1186/s13046-017-0516-2.
9
Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.蛋白质组学筛选确定钙网蛋白是一种miR-27a直接靶点,可抑制结直肠癌中MHC I类分子在细胞表面的表达。
Cell Death Dis. 2016 Feb 25;7(2):e2120. doi: 10.1038/cddis.2016.28.
10
miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.靶向RXRα的miR-27a-3p通过激活Wnt/β-连环蛋白通路促进结直肠癌进展。
Oncotarget. 2017 Jul 26;8(47):82991-83008. doi: 10.18632/oncotarget.19635. eCollection 2017 Oct 10.

引用本文的文献

1
Association of lncRNA MEG3 rs941576 polymorphism, expression profile, and its related targets with the risk of obesity-related colorectal cancer: potential clinical insights.长链非编码 RNA MEG3 rs941576 多态性、表达谱及其相关靶基因与肥胖相关结直肠癌风险的关联:潜在的临床见解。
Sci Rep. 2024 May 4;14(1):10271. doi: 10.1038/s41598-024-60265-6.
2
Potential diagnostic role of circulating MiRNAs in colorectal cancer.循环 miRNAs 在结直肠癌中的潜在诊断作用。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320221144565. doi: 10.1177/03946320221144565.
3
Lipid Handling Protein Gene Expression in Colorectal Cancer: CD36 and Targeting miRNAs.

本文引用的文献

1
Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer.循环外泌体 miR-27a 和 miR-130a 可作为结直肠癌的新型诊断和预后生物标志物。
Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):746-754. doi: 10.1158/1055-9965.EPI-18-0067. Epub 2018 May 8.
2
The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer.微小RNA特征作为结直肠癌不同临床阶段诊断生物标志物的作用
Cell J. 2018 Jul;20(2):220-230. doi: 10.22074/cellj.2018.5366. Epub 2018 Mar 18.
3
[Prediction of EGFR blockade responses in metastatic colorectal carcinoma].
结直肠癌中脂质处理蛋白基因表达:CD36 与靶向微小 RNA
Life (Basel). 2022 Dec 16;12(12):2127. doi: 10.3390/life12122127.
4
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer.在前列腺癌中,miR-31-3p通过直接靶向GABBR2发挥肿瘤抑制作用。
Front Oncol. 2022 Aug 18;12:945057. doi: 10.3389/fonc.2022.945057. eCollection 2022.
5
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.头颈部癌症中有前景的生物标志物:最具临床意义的 miRNAs。
Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257.
6
Study of microRNA expression profiling as biomarkers for colorectal cancer patients in Lebanon.黎巴嫩结直肠癌患者中作为生物标志物的微小RNA表达谱研究。
Mol Clin Oncol. 2022 Feb;16(2):39. doi: 10.3892/mco.2021.2473. Epub 2021 Dec 21.
7
Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.构建并分析肺腺癌中与生存相关的竞争性内源性 RNA 网络。
Biomed Res Int. 2021 Feb 11;2021:4093426. doi: 10.1155/2021/4093426. eCollection 2021.
8
miR‑31 promotes tumorigenesis in ulcerative colitis‑associated neoplasia via downregulation of SATB2.miR-31 通过下调 SATB2 促进溃疡性结肠炎相关肿瘤发生。
Mol Med Rep. 2020 Dec;22(6):4801-4809. doi: 10.3892/mmr.2020.11573. Epub 2020 Oct 8.
9
MicroRNA-34a Inhibition Alleviates Lung Injury in Cecal Ligation and Puncture Induced Septic Mice.microRNA-34a 抑制减轻盲肠结扎穿刺诱导的脓毒症小鼠肺损伤。
Front Immunol. 2020 Aug 13;11:1829. doi: 10.3389/fimmu.2020.01829. eCollection 2020.
10
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.血清微小RNA-592可作为结直肠癌早期诊断的一种新型潜在生物标志物。
Oncol Lett. 2020 Aug;20(2):1119-1126. doi: 10.3892/ol.2020.11682. Epub 2020 May 28.
Cesk Patol. 2018 Spring;54(1):17-21.
4
Technical Validation of a Reverse-Transcription Quantitative Polymerase Chain Reaction In Vitro Diagnostic Test for the Determination of MiR-31-3p Expression Levels in Formalin-Fixed Paraffin-Embedded Metastatic Colorectal Cancer Tumor Specimens.用于测定福尔马林固定石蜡包埋转移性结直肠癌肿瘤标本中MiR-31-3p表达水平的逆转录定量聚合酶链反应体外诊断测试的技术验证
Biomark Insights. 2018 Mar 16;13:1177271918763357. doi: 10.1177/1177271918763357. eCollection 2018.
5
Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.差异 miRNA 表达与结直肠癌肝转移和腹膜转移的相关性研究。
BMC Cancer. 2018 Feb 20;18(1):201. doi: 10.1186/s12885-018-4043-0.
6
MicroRNA Expression in - and -mutated Colorectal Cancers.微小RNA在KRAS和NRAS突变型结直肠癌中的表达
Anticancer Res. 2018 Feb;38(2):677-683. doi: 10.21873/anticanres.12272.
7
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial.KRAS野生型转移性结直肠癌患者中miR-31-3p表达与西妥昔单抗疗效的关联:新EPOC试验的事后分析
Oncotarget. 2017 Sep 27;8(55):93856-93866. doi: 10.18632/oncotarget.21291. eCollection 2017 Nov 7.
8
Novel circulating microRNAs expression profile in colon cancer: a pilot study.结肠癌中新型循环微小RNA表达谱:一项初步研究。
Eur J Med Res. 2017 Nov 29;22(1):51. doi: 10.1186/s40001-017-0294-5.
9
miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.靶向RXRα的miR-27a-3p通过激活Wnt/β-连环蛋白通路促进结直肠癌进展。
Oncotarget. 2017 Jul 26;8(47):82991-83008. doi: 10.18632/oncotarget.19635. eCollection 2017 Oct 10.
10
microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.microRNA-193a-3p 在 BRAF 突变型结直肠癌中特异性下调并发挥肿瘤抑制作用。
BMC Cancer. 2017 Nov 7;17(1):723. doi: 10.1186/s12885-017-3739-x.